World's Best Scientists 2026 revealed!
Odile Launay

Odile Launay

D-Index & Metrics

Immunology

D-Index
68
Citations
18060
World Ranking
2575
National Ranking
107

Odile Launay publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Odile Launay sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 485 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Odile Launay D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Odile Launay sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Odile Launay is affiliated with Inserm in France and has an extensive publication record primarily in the field of medicine, with a strong focus on infectious diseases and epidemiology. Their research covers a broad range of topics related to vaccines, viral infections, and public health.

Launay's main fields of study include:

  • Medicine

Their subfields of study emphasize:

  • Infectious Diseases
  • Epidemiology
  • Health
  • Public Health, Environmental and Occupational Health
  • General Health Professions

The core research topics addressed by Launay are:

  • Vaccine Coverage and Hesitancy
  • SARS-CoV-2 and COVID-19 Research
  • Influenza Virus Research Studies
  • COVID-19 Clinical Research Studies
  • Respiratory viral infections research
  • Viral Infections and Outbreaks Research
  • COVID-19 epidemiological studies

Significant recent publications include:

  • Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial, 2021, The Lancet Infectious Diseases
  • Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review, 2021, Clinical Microbiology and Infection
  • Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial, 2020, The Lancet Infectious Diseases
  • PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study, 2020, The Lancet Infectious Diseases
  • Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement, 2020, Frontiers in Immunology

Launay frequently collaborates with several co-authors, including:

  • Élisabeth Botelho-Nevers
  • Paul Loubet
  • Marie Lachâtre
  • Xavier de Lamballerie
  • Amandine Gagneux-Brunon

Publication venues where Launay has contributed most include:

  • Médecine et Maladies Infectieuses Formation
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Microbiology and Infection
  • Human Vaccines & Immunotherapeutics
  • Vaccine

Best Publications

  • A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation

    Patrick Peretti-Watel;Valérie Seror;Sébastien Cortaredona;Odile Launay

  • Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial

    Jean-Louis Bresson;Christian Perronne;Odile Launay;Catherine Gerdil

  • 2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1) pdm09 and B among elderly people in Europe: results from the I-MOVE plus project

    M. Rondy;A. Larrauri;I. Casado;V. Alfonsi

  • Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study.

    Françoise Dromer;Simone Mathoulin-Pélissier;Odile Launay;Olivier Lortholary;Olivier Lortholary

  • Tuberculosis in HIV-infected patients: a comprehensive review

    L. Aaron;D. Saadoun;I. Calatroni;O. Launay

  • Vaccine Hesitancy Among General Practitioners and Its Determinants During Controversies: A National Cross-sectional Survey in France

    Pierre Verger;Lisa Fressard;Fanny Collange;Arnaud Gautier

  • The French public's attitudes to a future COVID-19 vaccine: The politicization of a public health issue.

    Jeremy K Ward;Caroline Alleaume;Patrick Peretti-Watel

  • Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.

    Florence Ader;Maude Bouscambert-Duchamp;Maya Hites;Nathan Peiffer-Smadja;Nathan Peiffer-Smadja

  • Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness

    Ann R. Falsey;Janet E. McElhaney;Jiri Beran;Gerrit A. van Essen

  • Mucosal Imprinting of Vaccine-Induced CD8+ T Cells Is Crucial to Inhibit the Growth of Mucosal Tumors

    Federico Sandoval;Federico Sandoval;Magali Terme;Magali Terme;Mevyn Nizard;Mevyn Nizard;Cécile Badoual;Cécile Badoual

  • Knowledge, attitudes and vaccination coverage of healthcare workers regarding occupational vaccinations.

    P. Loulergue;F. Moulin;G. Vidal-Trecan;Z. Absi

  • Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review

    Simon Galmiche;Liem Binh Luong Nguyen;Eric Tartour;Xavier de Lamballerie

  • Long-term Immune Responses to Vaccination in HIV-Infected Patients: A Systematic Review and Meta-Analysis

    Solen Kernéis;Odile Launay;Clément Turbelin;Clément Turbelin;Frédéric Batteux

  • Safety and Immunogenicity of 4 Intramuscular Double Doses and 4 Intradermal Low Doses vs Standard Hepatitis B Vaccine Regimen in Adults With HIV-1 A Randomized Controlled Trial

    Odile Launay;Diane van der Vliet;Arielle R. Rosenberg;Marie-Louise Michel

  • The French health pass holds lessons for mandatory COVID-19 vaccination

    Unknown

  • AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial

    Janet E McElhaney;Jiri Beran;Jeanne-Marie Devaster;Meral Esen

  • Gag Mutations Strongly Contribute to HIV-1 Resistance to Protease Inhibitors in Highly Drug-Experienced Patients besides Compensating for Fitness Loss

    Elisabeth Dam;Romina Quercia;Bärbel Glass;Diane Descamps

  • Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients

    Caroline Charlier;Corneliu Henegar;Odile Launay;Christian Pagnoux

  • Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial.

    A J Pollard;O Launay;Lelievre J-D.;C Lacabaratz

  • Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the international COMORA cohort.

    Ihsane Hmamouchi;Ihsane Hmamouchi;Kevin Winthrop;Odile Launay;Maxime Dougados

  • A report on the status of vaccination in Europe

    Shazia Sheikh;Eliana Biundo;Soizic Courcier;Oliver Damm

  • Protective effect of A/H1N1 vaccination in immune-mediated disease—a prospectively controlled vaccination study

    Sabine Adler;Anne Krivine;Janine Weix;Flore Rozenberg

Frequent Co-Authors

Fabrice Carrat
Fabrice Carrat Sorbonne University
François Goffinet
François Goffinet Université Paris Cité
Loïc Guillevin
Loïc Guillevin Université Paris Cité
Gilles Pialoux
Gilles Pialoux Tenon Hospital
Bruno Lina
Bruno Lina Claude Bernard University Lyon 1
Luc Mouthon
Luc Mouthon Université Paris Cité
Flore Rozenberg
Flore Rozenberg Université Paris Cité
Jean-Paul Viard
Jean-Paul Viard Assistance Publique – Hôpitaux de Paris
Isabelle Poizot-Martin
Isabelle Poizot-Martin Aix-Marseille University

External Links

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing advanced nursing degrees can open diverse career opportunities in healthcare settings focused on immune-related conditions. Specialized programs such as pmhnp programs online with best clinical placement provide hands-on clinical experience, essential for those aiming to become Psychiatric Mental Health Nurse Practitioners. These programs combine immunology knowledge with mental health care, expanding therapeutic options.

Cost is a crucial consideration for prospective students. Fortunately, there are options such as the cheapest online pmhnp certificate programs that offer quality education without the high price tag. Such programs make advanced education accessible to more learners keen on integrating immunology with psychiatric nursing.

Career advancement often correlates with degree level and specialization. Those with a Doctor of Nursing Practice (DNP) can expect competitive compensation, with variations by region. To see the earning potential, refer to how much do dnp nurses make to better understand salary trends depending on location.

Additionally, nurses looking to shift their focus towards acute immunological care may consider further specialization. Programs like acnp programs facilitate the transition from Family Nurse Practitioner roles to Acute Care Nurse Practitioner positions, aligning with the growing demand for expert care in immunology-related acute conditions.

Best Scientists Citing Odile Launay

Trending Scientists

Recently Published Articles